UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder

Abstract Aim This study aims to analyze the health‐related quality of life (HRQoL) and safety outcomes in attention‐deficit/hyperactivity disorder (ADHD) patients treated with cannabis‐based medicinal products (CBMPs). Methods Patients were identified from the UK Medical Cannabis Registry. Primary o...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mikael H. Sodergren
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Wiley 2023-12-01
Serie:	Neuropsychopharmacology Reports
Ämnen:	attention deficit disorder with hyperactivity cannabidiol cannabis psychiatry tetrahydrocannabinol
Länkar:	https://doi.org/10.1002/npr2.12400
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!